about
Drug Carrier for Photodynamic Cancer TherapyNanoparticles for imaging and treating brain cancerDasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activityNanoparticle-Programmed Surface for Drug Release and Cell Regulation via Reversible Hybridization ReactionA Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal TherapyMorin Flavonoid Adsorbed on Mesoporous Silica, a Novel Antioxidant NanomaterialTargeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.Emergence and Utility of Nonspherical Particles in BiomedicinePromises and pitfalls of intracellular delivery of proteins.Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles.Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platformOvercoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy.The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.Size-tunable supramolecular nanoparticles mediated by ternary cucurbit[8]uril host-guest interactions.Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.Synergistic dual-targeting hydrogel improves targeting and anticancer effect of Taxol in vitro and in vivo.An efficient rose bengal based nanoplatform for photodynamic therapy.Adsorption of doxorubicin on citrate-capped gold nanoparticles: insights into engineering potent chemotherapeutic delivery systems.Following the stability of amphiphilic nanoaggregates by using intermolecular energy transfer.
P2860
Q26782780-DBC4D970-B996-4BBA-B6E9-182231038D39Q28394053-D176AD59-CEDB-4DE4-A113-0E4E625859E7Q28468632-1234D247-D8D2-4EED-9AFE-E29771F0755AQ33773285-544A68A1-2196-46A5-8EFB-5F47A28BD24BQ35686257-1BD6447A-BCB8-4FBE-8E16-A34F152456ADQ36182007-F853D550-2AC4-4CB3-A28D-0957D0F4C447Q36498783-08B93D99-8D10-431C-ADB8-481FE940FEA7Q36892538-9D4C6B96-EB5E-4DB0-A20A-52B84C8C5DBFQ38240926-901C472B-663F-4291-9AF1-5D0403E1734FQ38616382-15801668-CCB3-46C2-830E-E36E93D4B9B1Q38724698-77A90A3F-0C26-49E2-ACD3-F91F7BE6DBA7Q38848959-4B3421CB-3C73-4B79-A896-EF6F5C8752FFQ39014347-AC527806-0E37-46BF-9012-E4AD0B6954AFQ42730813-0D8C5D13-4868-423D-BFCF-4E11DD7D8D9BQ44374679-90D93FA5-0E83-4CFD-8A93-26CED7FD519FQ47327036-254DF915-B14A-4614-88A2-42262FAA1FB5Q50446958-2708C250-4C36-443D-A25A-89A4B3F56F82Q50451301-0AC43BF7-1E4B-45BE-AD8C-0B9AAADAE194Q51653532-878ABF99-887A-4EFB-AA44-AC31A3ECC642Q51747720-1A4D83E2-7D4C-45FF-A8E2-40FFE965D86C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoparticle mediated non-covalent drug delivery
@en
Nanoparticle mediated non-covalent drug delivery.
@nl
type
label
Nanoparticle mediated non-covalent drug delivery
@en
Nanoparticle mediated non-covalent drug delivery.
@nl
prefLabel
Nanoparticle mediated non-covalent drug delivery
@en
Nanoparticle mediated non-covalent drug delivery.
@nl
P2860
P1476
Nanoparticle mediated non-covalent drug delivery
@en
P2093
Clemens Burda
Tennyson Doane
P2860
P304
P356
10.1016/J.ADDR.2012.05.012
P407
P577
2012-06-01T00:00:00Z